Larazotide
Also known as: Larazotide acetate, AT-1001, INN-202, GGVLVQPG
Synthetic eight-amino-acid peptide that acts as a zonulin antagonist and tight-junction regulator, helping restore and maintain intestinal epithelial barrier function (reducing paracellular 'leaky gut' permeability). It was developed (as larazotide acetate, AT-1001 / INN-202) primarily for celiac disease as an adjunct to a gluten-free diet. It is not FDA-approved: a Phase 3 trial (CeDLara) in celiac disease was discontinued for futility, and the compound remains investigational with no approved human indication. The acetate salt form carries CAS 881851-50-9.
Common research uses
Pricing for Larazotide
Live vendor pricing, normalized to $/mg so sizes compare fairly — fused with each seller's Merit trust score and latest independent COA purity. Prices refresh daily.
No sellers for Larazotide are indexed yet — we add vendors and their prices as we find them.
COAs for Larazotide
2 third-party tests. Each card links to the full report.
Research use only — not for human consumption and not approved by the FDA. Nothing here is medical advice.